Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT

被引:90
|
作者
Schmid, Christoph [1 ]
Labopin, Myriam [2 ,3 ]
Schaap, Nicolaas [4 ]
Veelken, Hendrik [5 ]
Schleuning, Michael [6 ]
Stadler, Michael [7 ]
Finke, Juergen [8 ]
Hurst, Erin [9 ]
Baron, Frederic [10 ]
Ringden, Olle [11 ]
Bug, Gesine [12 ]
Blaise, Didier [13 ]
Tischer, Johanna [14 ]
Bloor, Adrian [15 ]
Esteve, Jordi [16 ]
Giebel, Sebastian [17 ,18 ]
Savani, Bipin [19 ]
Gorin, Norbert-Claude [2 ,3 ]
Ciceri, Fabio [20 ]
Mohty, Mohamad [2 ,3 ]
Nagler, Anton [21 ]
机构
[1] Univ Munich, Dept Haematol & Oncol, Klinikum Augsburg, Stenglinstr 2, D-86156 Augsburg, Germany
[2] Univ Paris 06, Paris, France
[3] EBMT Data Off, Paris, France
[4] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands
[5] Leiden Univ Hosp, BMT Ctr Leiden, Leiden, Netherlands
[6] Deutsch Klin Diagnost, KMT Zentrum, Wiesbaden, Germany
[7] Hannover Med Sch, Dept Haematol & Oncol, Hannover, Germany
[8] Univ Freiburg, Dept Med Haematol & Oncol, Freiburg, Germany
[9] NCCN Freeman Hosp, Bone Marrow Transplant Unit, Newcastle Upon Tyne, Tyne & Wear, England
[10] Univ Liege, Dept Med, Div Haematol, Liege, Belgium
[11] Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Therapeut Immunol, Karolinska Inst, Stockholm, Sweden
[12] Univ Klinikum, Dept Med 2, Haematol & Oncol, Frankfurt, Germany
[13] Marseille Inst Paoli Calmettes, Programme Transplantat & Therapie, Cellulaire Ctr Rech Cancerol, Marseille, France
[14] Ludwig Maximilians Univ Munchen, Dept Med 3, Haematol & Oncol, Munich, Germany
[15] Christie NHS Fdn Trust, Stein Cell Transplantat Unit, Manchester, Lancs, England
[16] Hosp Clin Barcelona, IDIBAPS, Dept Haematol, Barcelona, Spain
[17] Maria Sklodowska Curie Canc Ctr, Gliwice, Poland
[18] Inst Oncol, Gliwice Branch, Gliwice, Poland
[19] Vanderbilt Univ Sch Med, Long Term Transplant Clin, Nashville, TN USA
[20] Univ Milan, Dept Haematol, Osp San Raffaele, Milan, Italy
[21] Chaim Sheba Med Ctr, Tel Hashomer, Israel
关键词
acute leukaemia; allogeneic stem cell transplantation; DLI; relapse prevention; ACUTE MYELOID-LEUKEMIA; STAGE ACUTE-LEUKEMIA; SURVIVAL; PREVENTION; ANTIGEN;
D O I
10.1111/bjh.15691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Strategies for relapse prevention after allogeneic transplantation in acute leukaemia are warranted. A registry-based matched-pair analysis evaluated the efficacy of prophylactic donor lymphocyte infusion (proDLI). Adults receiving proDLI in complete remission (CR) and controls were pair-matched for age, diagnosis, cytogenetics, stage, donor, gender, conditioning and T-cell depletion. Eighty-nine pairs were identified (median follow-up: 6.9 years). Within the entire cohort, no difference was observed. However, among patients with high-risk acute myeloid leukaemia (AML) (unfavourable cytogenetics and/or transplanted beyond first CR), proDLI recipients had improved overall survival (69.8% vs. 40.2% in controls, P = 0.027). ProDLI has moderate efficacy, but can contribute to improved outcome in high-risk AML.
引用
收藏
页码:782 / 787
页数:6
相关论文
共 50 条
  • [41] Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation
    You Yong
    Li Qiu-bai
    Chen Zhi-chao
    Li Wei-ming
    Xia Ling-hui
    Zhou Hao
    Zou Ping
    CHINESE MEDICAL JOURNAL, 2008, 121 (18) : 1770 - 1774
  • [42] Novel strategies to prevent relapse after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes
    Kekre, Natasha
    Koreth, John
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (02) : 116 - 122
  • [43] Outcome of Donor Lymphocyte Infusion after T Cell-depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes
    Krishnamurthy, Pramila
    Potter, Victoria T.
    Barber, Linda D.
    Kulasekararaj, Austin G.
    Lim, Zi Yi
    Pearce, Rachel M.
    de Lavallade, Hugues
    Kenyon, Michelle
    Ireland, Robin M.
    Marsh, Judith C. W.
    Devereux, Stephen
    Pagliuca, Antonio
    Mufti, Ghulam J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (04) : 562 - 568
  • [44] Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
    Dholaria, Bhagirathbhai
    Savani, Bipin N.
    Labopin, Myriam
    Luznik, Leo
    Ruggeri, Annalisa
    Mielke, Stephan
    Al Malki, Monzr M.
    Kongtim, Piyanuch
    Fuchs, Ephraim
    Huang, Xiao-Jun
    Locatelli, Franco
    Aversa, Franco
    Castagna, Luca
    Bacigalupo, Andrea
    Martelli, Massimo
    Blaise, Didier
    Ben Soussan, Patrick
    Arnault, Yolande
    Handgretinger, Rupert
    Roy, Denis-Claude
    O'Donnell, Paul
    Bashey, Asad
    Solomon, Scott
    Romee, Rizwan
    Lewalle, Philippe
    Gayoso, Jorge
    Maschan, Michael
    Lazarus, Hillard M.
    Ballen, Karen
    Giebel, Sebastian
    Baron, Frederic
    Ciceri, Fabio
    Esteve, Jordi
    Gorin, Norbert-Claude
    Spyridonidis, Alexandros
    Schmid, Christoph
    Ciurea, Stefan O.
    Nagler, Arnon
    Mohty, Mohamad
    HAEMATOLOGICA, 2020, 105 (01) : 47 - 58
  • [45] Azacitidine and donor lymphocyte infusion for patients with relapsed acute myeloid leukemia and myelodysplastic syndromes after allogeneic hematopoietic stem cell transplantation: A meta-analysis
    Li, Xuefeng
    Wang, Wen
    Zhang, Xin
    Wu, Yu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [46] Donor lymphocyte infusion after allogeneic haematopoietic cell transplantation for haematological malignancies: basic considerations and best practice recommendations from the EBMT
    Pagliuca, Simona
    Schmid, Christoph
    Santoro, Nicole
    Simonetta, Federico
    Battipaglia, Giorgia
    Guillaume, Thierry
    Greco, Raffaella
    Onida, Francesco
    Sanchez-Ortega, Isabel
    Yakoub-Agha, Ibrahim
    Kuball, Jurgen
    Hazenberg, Mette
    Ruggeri, Annalisa
    LANCET HAEMATOLOGY, 2024, 11 (06): : e448 - e458
  • [47] Donor Lymphocyte Infusions After Allogeneic Stem Cell Transplantation in Acute Leukemia: A Survey From the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
    Patriarca, Francesca
    Sperotto, Alessandra
    Lorentino, Francesca
    Oldani, Elena
    Mammoliti, Sonia
    Isola, Miriam
    Picardi, Alessandra
    Arcese, William
    Saporiti, Giorgia
    Sorasio, Roberto
    Mordini, Nicola
    Cavattoni, Irene
    Musso, Maurizio
    Borghero, Carlo
    Mic, Caterina
    Fanin, Renato
    Bruno, Benedetto
    Ciceri, Fabio
    Bonifazi, Francesca
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [48] Panobinostat and decitabine prior to donor lymphocyte infusion in allogeneic stem cell transplantation
    Kalin, Burak
    van Norden, Yvette
    van Gelder, Michel
    Breems, Dimitri
    Maertens, Johan
    Jongen-Lavrencic, Mojca
    Broers, Annoek E. C.
    Braakman, Eric
    Grob, Tim
    Zeijlemaker, Wendelien
    Ossenkoppele, Gert J.
    Meijer, Ellen
    Cornelissen, Jan J.
    BLOOD ADVANCES, 2020, 4 (18) : 4430 - 4437
  • [49] Comparison of second transplantation and donor lymphocyte infusion for donor mixed chimerism after allogeneic stem cell transplantation for nonmalignant diseases
    Umeda, Katsutsugu
    Adachi, Souichi
    Tanaka, Shiro
    Miki, Mizuka
    Okada, Keiko
    Hashii, Yoshiko
    Inoue, Masami
    Cho, Yuko
    Koh, Katsuyoshi
    Goto, Hiroaki
    Kajiwara, Ryosuke
    Hyakuna, Nobuyuki
    Kato, Koji
    Morio, Tomohiro
    Yabe, Hiromasa
    PEDIATRIC BLOOD & CANCER, 2016, 63 (12) : 2221 - 2229
  • [50] Comparison of the safety and efficacy of prophylactic donor lymphocyte infusion after haploidentical versus matched-sibling PBSCT in very high-risk acute myeloid leukemia
    Gao, Xiao-Ning
    Lin, Ji
    Wang, Li-Jun
    Li, Fei
    Li, Hong-Hua
    Wang, Shu-Hong
    Huang, Wen-Rong
    Gao, Chun-Ji
    Yu, Li
    Liu, Dai-Hong
    ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1267 - 1277